H-Cyte, Inc. engages in the design and marketing of proprietary medical devices for commercial use in the United States and Europe. It offers DenerveX device, which provides pain relief from facet joint syndrome. The company was founded by Scott M. W. Haufe and Steven Gorlin on July 30, 2013 and is headquartered in Tampa, FL.
This security is traded over-the-counter, or OTC. We don't always have accurate pricing data on OTC stocks.
$2.21 OTCQB
As of 02/07/2023 OTCMarkets
2022 © Stock Market MBA, Inc.